DBC-664 in Adult Patients With Solid Tumors

Clinical trial NCT07705035 · RECRUITING

Trial details

NCT number: NCT07705035
Sponsor: Duboce Biopharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Germ Cell Tumor Lung Adenocarcinoma Gastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma Urothelial Carcinoma Endometrial Adenocarcinoma Ovarian Adenocarcinoma

Start date: 2026-07-17
Primary completion: 2030-04-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.